Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0N9DU
|
|||
Former ID |
DIB020052
|
|||
Drug Name |
indirubin derivative E804
|
|||
Synonyms |
indirubin E804; compound 2 [PMID: 21632247]
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)C(=C(N2)C3=C4C=CC=CC4=NC3=O)NOCCC(CO)O
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Tyrosine-protein kinase EIF2AK2 (p68) | Target Info | Inhibitor | [1] |
Panther Pathway | Apoptosis signaling pathway | |||
Pathway Interaction Database | Signaling events mediated by TCPTP | |||
Ceramide signaling pathway | ||||
PDGFR-beta signaling pathway | ||||
Reactome | ISG15 antiviral mechanism | |||
WikiPathways | Type II interferon signaling (IFNG) | |||
Host Interactions with Influenza Factors | ||||
Integrated Pancreatic Cancer Pathway | ||||
Translation Factors |
References | Top | |||
---|---|---|---|---|
REF 1 | Identification of new inhibitors of protein kinase R guided by statistical modeling. Bioorg Med Chem Lett. 2011 Jul 1;21(13):4108-14. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.